Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMYT | BMY | AMGN | GILD | VRTX |
| Company | Amryt Pharma Plc ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.71 | 44.68 | 265.72 | 65.50 | 393.52 |
| High | 14.76 | 45.37 | 271.68 | 66.35 | 399.68 |
| Low | 14.63 | 44.34 | 265.72 | 64.63 | 393.49 |
| Last | 14.70 | 44.85 | 269.98 | 65.42 | 397.48 |
| Change | +0.01 | +0.15 | +0.60 | +0.15 | -0.22 |
| % Change | +0.07% | +0.34% | +0.22% | +0.23% | -0.06% |
| Volume | 2,389,400 | 21,281,900 | 2,436,900 | 12,382,400 | 682,400 |
| 20-Day Average Volume | 650,490 | 13,205,370 | 2,156,940 | 7,062,390 | 943,625 |
| Previous Close | 14.69 | 44.70 | 269.38 | 65.27 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.59 | 49.47 | 269.99 | 68.29 | 401.28 |
| 20-Day Raw Stochastic | 75.00% | 5.16% | 40.03% | 9.20% | 21.25% |
| 20-Day Relative Strength | 72.77% | 29.15% | 45.47% | 29.21% | 42.53% |
| Weighted Alpha | +10.40 | -34.43 | +9.45 | -23.49 | +14.78 |
| Today's Opinion | 88% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 96% Buy | 8% Buy | 40% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.62% since 04/03/23 | -8.34% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | +0.81% since 04/19/24 |
| Low | 14.58 on 04/04/23 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 |
| High | 14.76 on 04/11/23 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +0.62% since 03/10/23 | -14.65% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | -5.01% since 03/26/24 |
| Low | 14.52 on 03/16/23 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 14.76 on 04/11/23 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -0.47% since 01/11/23 | -9.76% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | -7.60% since 01/26/24 |
| Low | 14.52 on 03/16/23 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 14.77 on 01/13/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +116.18% since 10/11/22 | -15.33% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +10.02% since 10/26/23 |
| Low | 6.50 on 10/28/22 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
| High | 14.77 on 01/13/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 940,256 | 90,596,128 | 144,488,960 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 63,963 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 222,540,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 1,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 61,126,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -20,795,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.84 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/03/22 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/03/23 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 734.50 | 6.51 | 14.64 | 9.98 | 29.82 |